Marrone Bio Innovations to Present at the June 2020 Virtual Investor Summit
Marrone Bio Innovations (NASDAQ: MBII) will present at the June 2020 Virtual Investor Summit from June 9-12, 2020. Management will host virtual one-on-one investor meetings and deliver a presentation on June 9 at 3:55 p.m. Eastern Time. Participants must register for the invite-only conference. Marrone Bio Innovations is dedicated to sustainable bioprotection and plant health solutions, with a portfolio that includes over 400 patents and numerous products aimed at improving agricultural sustainability. For more details, visit www.marronebio.com.
- None.
- None.
Insights
Analyzing...
DAVIS, Calif., May 26, 2020 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI), an international leader in sustainable bioprotection and plant health solutions, today announced that management will present at the June 2020 Virtual Investor Summit on June 9-12, 2020.
Marrone Bio Innovations management will host virtual one-on-one investor meetings throughout the event and is scheduled to present as follows:
Virtual Investor Summit
Date: Tuesday, June 9, 2020
Time: 3:55 p.m. Eastern time (12:55 p.m. Pacific time)
Webcast: https://www.webcaster4.com/Webcast/Page/2038/35033
Conference participation is by invitation only and registration is mandatory. For more information, or to schedule a virtual one-on-one meeting, please contact your conference representative.
About Marrone Bio Innovations
Marrone Bio Innovations Inc. (NASDAQ: MBII) is a growth-oriented company leading the movement to a more sustainable world through the discovery, development and sale of innovative biological products for crop protection, plant health and waterway systems treatment that help customers operate more sustainably while increasing their return on investment. MBI has screened over 18,000 microorganisms and 350 plant extracts, leveraging its in-depth knowledge of plant and soil microbiomes enhanced by advanced molecular technologies and natural product chemistry to rapidly develop seven product lines. Supported by a robust portfolio of over 400 issued and pending patents, MBI’s currently available commercial products are Regalia®, Stargus®, Grandevo®, Venerate®, Majestene®, Haven®, Pacesetter™, Zelto® Jet Oxide® and Jet Ag® and Zequanox®, with a next-generation insecticide-nematicide, a breakthrough bioherbicide and a biofumigant in the Company’s product pipeline. MBI’s Pro Farm Finland-based subsidiary employs a proprietary technology derived from wood waste to stimulate plant growth and improve plant health, resulting in improved yields and crop quality. Products include UBP™ 110, Foramin®, UBP™ Seed Treatment, Foramin® ST.
Learn more about Marrone Bio Innovations at www.marronebio.com. We also use our investor relations website, https://investors.marronebio.com, as well as our corporate Twitter account, @Marronebio, as means of disclosing material non-public information, and encourage our investors and others to monitor and review the information we make public in these locations. Follow us on social media: Twitter, LinkedIn and Instagram.
Investor Relations Contact:
Greg Falesnik, Managing Director
MZ Group – MZ North America
Main: 949-385-6449
MBII@mzgroup.us
www.mzgroup.us
FAQ
When will Marrone Bio Innovations present at the June 2020 Virtual Investor Summit?
How can I attend the June 2020 Virtual Investor Summit for Marrone Bio Innovations?
What is the focus of Marrone Bio Innovations?
What products does Marrone Bio Innovations offer?
Where can I find more information about Marrone Bio Innovations?
